Clinical Trial Update: Efficacy and Safety of MEthylprednisolone Administered Intravenously for the Treatment of Patients With Active AnkyLosing spondyLitis (METALL) [Phase 2]

View source ↗

Summary

Phase 2 trial METALL evaluates intravenously administered methylprednisolone for active ankylosing spondylitis, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Saratov State Medical University | Conditions: Ankylosing Spondylitis | Phase 2 | Status: UNKNOWN